Green MRI for neuroimaging: monitoring brain tumors using non-contrast sequences
- 1Department of Radiology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka City, Tokyo 181-8611 Japan
Abstract
The emerging concept of "Green Radiology" aims to mitigate the environmental impact of medical imaging while maintaining high standards of patient care. Among various modalities, MRI is particularly resource-intensive. This review focuses on the clinical feasibility and significance of minimizing gadolinium-based contrast agent (GBCA) administration in neuroimaging, specifically for the longitudinal follow-up of brain tumors. Key points of this review are as follows: (1) Rationales for "Green" MRI: Beyond patient safety concerns such as adverse reactions and gadolinium retention in the brain and bone, GBCAs pose significant environmental risks due to their persistence in global water systems and potential eco-toxicity. (2) Feasibility in extra-axial tumors: For many extra-axial lesions, including meningiomas, schwannomas, and macro-PitNETs (≥ 10 mm), non-contrast MRI sequences—leveraging the inherent contrast of cerebrospinal fluid—provide sufficient diagnostic information for routine surveillance. (3) Strategies for intra-axial tumors: While GBCAs remain the gold standard for high-grade gliomas and metastases, a "non-contrast-first" strategy may be viable for tumors with indolent progression. In these cases, GBCAs can be reserved for instances where interval changes are first identified on unenhanced sequences. (4) Advanced contrast-free alternatives: Non-invasive techniques such as arterial spin labeling (ASL), chemical exchange saturation transfer (CEST) imaging, and advanced diffusion-weighted imaging (DWI) offer powerful metabolic and microstructural insights without the need for chemical agents. (5) Future perspectives: Deep learning-based technologies, including "virtual contrast" synthesis and dosage reduction algorithms, hold immense potential to harmonize diagnostic excellence with environmental sustainability. Transitioning toward "Green Neuroradiology" through the judicious use of GBCAs and the adoption of advanced non-contrast sequences is a practical and necessary step for sustainable radiological practice. This review highlights the concept of "Green MRI" for sustainable neuroimaging. We discuss the clinical and environmental rationales for minimizing the use of GBCAs, particularly in the follow-up of extra-axial tumors. Furthermore, we explore how advanced sequences and deep learning provide viable, contrast-free alternatives for future radiological practice.
Related
- Radiologist-guided multimodal fusion network for differentiating parotid tumors on 3D non-contrast CT
- Whole-genome sequencing-based tumor-informed circulating tumor DNA monitoring for early detection of recurrence in patients with solid tumors
- Tumor-Informed ddPCR for Personalized Longitudinal ctDNA Monitoring in Advanced Solid Tumors: Molecular–Radiological Concordance and Molecular Lead Time
- Ultraprocessed Foods, Neuroimaging, and Interpretation of Observational Evidence
- Effects of chronic oxytocin administration on white matter microstructure in autistic adults: a pilot pharmaco-neuroimaging DTI study
BibTeX
@article{tsuchiya2026green,
title = {{Green MRI for neuroimaging: monitoring brain tumors using non-contrast sequences}},
author = {Kazuhiro Tsuchiya and Miho Gomyo and Shichiro Katase and Kenichi Yokoyama},
journal = {Japanese Journal of Radiology},
year = {2026},
month = jul,
doi = {10.1007/s11604-026-02045-y},
url = {https://doi.org/10.1007/s11604-026-02045-y},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Green MRI for neuroimaging: monitoring brain tumors using non-contrast sequences
AU - Kazuhiro Tsuchiya
AU - Miho Gomyo
AU - Shichiro Katase
AU - Kenichi Yokoyama
PY - 2026
DA - 2026/07/10
JO - Japanese Journal of Radiology
DO - 10.1007/s11604-026-02045-y
UR - https://doi.org/10.1007/s11604-026-02045-y
AB - The emerging concept of "Green Radiology" aims to mitigate the environmental impact of medical imaging while maintaining high standards of patient care. Among various modalities, MRI is particularly resource-intensive. This review focuses on the clinical feasibility and significance of minimizing gadolinium-based contrast agent (GBCA) administration in neuroimaging, specifically for the longitudinal follow-up of brain tumors. Key points of this review are as follows: (1) Rationales for "Green" MRI: Beyond patient safety concerns such as adverse reactions and gadolinium retention in the brain and bone, GBCAs pose significant environmental risks due to their persistence in global water systems and potential eco-toxicity. (2) Feasibility in extra-axial tumors: For many extra-axial lesions, including meningiomas, schwannomas, and macro-PitNETs (≥ 10 mm), non-contrast MRI sequences—leveraging the inherent contrast of cerebrospinal fluid—provide sufficient diagnostic information for routine surveillance. (3) Strategies for intra-axial tumors: While GBCAs remain the gold standard for high-grade gliomas and metastases, a "non-contrast-first" strategy may be viable for tumors with indolent progression. In these cases, GBCAs can be reserved for instances where interval changes are first identified on unenhanced sequences. (4) Advanced contrast-free alternatives: Non-invasive techniques such as arterial spin labeling (ASL), chemical exchange saturation transfer (CEST) imaging, and advanced diffusion-weighted imaging (DWI) offer powerful metabolic and microstructural insights without the need for chemical agents. (5) Future perspectives: Deep learning-based technologies, including "virtual contrast" synthesis and dosage reduction algorithms, hold immense potential to harmonize diagnostic excellence with environmental sustainability. Transitioning toward "Green Neuroradiology" through the judicious use of GBCAs and the adoption of advanced non-contrast sequences is a practical and necessary step for sustainable radiological practice. This review highlights the concept of "Green MRI" for sustainable neuroimaging. We discuss the clinical and environmental rationales for minimizing the use of GBCAs, particularly in the follow-up of extra-axial tumors. Furthermore, we explore how advanced sequences and deep learning provide viable, contrast-free alternatives for future radiological practice.
SN - 1867-1071
SN - 1867-108X
ER -